Tc
Thu, Nov-23-06, 17:15
http://www.fda.gov/ohrms/dockets/ac/05/roster/2005-4101r1_-
Roster.htm
Panel Roster
April 11 to 13, 2005
General and Plastic Surgery Devices Panel
Michael J. Miller, MD Professor and Deputy Chairman
Department of Plastic Surgery University of Texas, MD
Anderson Cancer Center Houston, Texas
Michael J. Olding, MD Chief, Division of Plastic Surgery
Department of Surgery George Washington University School of
Medicine Washington, DC
---
Michael J. Miller, M.D., F.A.C.S., Associate Surgeon and
Associate Professor, Department of Plastic Surgery, Anderson
Cancer Center, University of Texas, Houston. Consultant for
ossseous tissue engineering, W. L. Gore, Inc.(1998). Patent
Application No.09,164,746, Subcutaneous Endoscopic Dissector
(Submitted 1998). (http://www.fda.gov/cdrh/panel/cv/cv244.doc;
accessed 3/14/05) Received $25,000 grant from Inamed to create
an informational CD-ROM on reconstructive breast surgery.
(Kaufman, Marc. Implant Panelist Received Grant From Maker,
Washington Post, 11/18/03, p.A2)
***
Michael J. Olding, M.D., Chief, Division of Plastic Surgery,
Department of Surgery, George Washington University,
Washington, D.C. Owned between $50,001 and $100,000 in stock
in a direct competitor of BioForm Medical, Inc. (http://www.f-
da.gov/ohrms/dockets/ac/06/waivers/2006-4233w-01-Olding-ack.p-
df; accessed 8/23/06)
---
http://www.bioformmedical.com/US/Bio_med/Company_Profile.htm
BioForm Medical, Inc. ("BioForm") is a privately-held medical
device company developing and commercializing injectable
implant products for soft and hard tissue augmentation.
***
TC
Roster.htm
Panel Roster
April 11 to 13, 2005
General and Plastic Surgery Devices Panel
Michael J. Miller, MD Professor and Deputy Chairman
Department of Plastic Surgery University of Texas, MD
Anderson Cancer Center Houston, Texas
Michael J. Olding, MD Chief, Division of Plastic Surgery
Department of Surgery George Washington University School of
Medicine Washington, DC
---
Michael J. Miller, M.D., F.A.C.S., Associate Surgeon and
Associate Professor, Department of Plastic Surgery, Anderson
Cancer Center, University of Texas, Houston. Consultant for
ossseous tissue engineering, W. L. Gore, Inc.(1998). Patent
Application No.09,164,746, Subcutaneous Endoscopic Dissector
(Submitted 1998). (http://www.fda.gov/cdrh/panel/cv/cv244.doc;
accessed 3/14/05) Received $25,000 grant from Inamed to create
an informational CD-ROM on reconstructive breast surgery.
(Kaufman, Marc. Implant Panelist Received Grant From Maker,
Washington Post, 11/18/03, p.A2)
***
Michael J. Olding, M.D., Chief, Division of Plastic Surgery,
Department of Surgery, George Washington University,
Washington, D.C. Owned between $50,001 and $100,000 in stock
in a direct competitor of BioForm Medical, Inc. (http://www.f-
da.gov/ohrms/dockets/ac/06/waivers/2006-4233w-01-Olding-ack.p-
df; accessed 8/23/06)
---
http://www.bioformmedical.com/US/Bio_med/Company_Profile.htm
BioForm Medical, Inc. ("BioForm") is a privately-held medical
device company developing and commercializing injectable
implant products for soft and hard tissue augmentation.
***
TC